Philip Scheltens
- Psychiatry and Mental health top 0.01%
- Dementia and Cognitive Impairment Research 674
- Neurology top 0.01%
- Neurological Disease Mechanisms and Treatments 155
- Cognitive Neuroscience top 0.01%
- Functional Brain Connectivity Studies 200
- EEG and Brain-Computer Interfaces 59
- Physiology top 0.01%
- Alzheimer's disease research and treatments 463
- Neurology top 0.01%
- Neurological Disease Mechanisms and Treatments 155
-
- Advanced Neuroimaging Techniques and Applications 125
-
- Cerebrovascular and Carotid Artery Diseases 63
-
- Health Systems, Economic Evaluations, Quality of Life 55
- Co-authors
- Frederik BarkhofWiesje M. van der FlierCornelis J. StamSerge A.R.B. RomboutsClifford R. JackMartin N. RossorYolande A.L. PijnenburgMaría C. Carrillo
- Journals
- Alzheimer s & Dementia (180 papers)Neurology (72 papers)Alzheimer s Research & Therapy (71 papers)
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
Philip Scheltens
1.2k papers receiving 98.7k citations
Hit Papers
Peers
Comparison fields: 5 of 214
- Psychiatry and Mental health 43.9k
- Neurology 18.2k
- Cognitive Neuroscience 29.8k
- Physiology 36.4k
- Neurology 13.0k
Countries citing papers authored by Philip Scheltens
This map shows the geographic impact of Philip Scheltens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Scheltens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Scheltens more than expected).
Fields of papers citing papers by Philip Scheltens
This network shows the impact of papers produced by Philip Scheltens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Scheltens. The network helps show where Philip Scheltens may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philip Scheltens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s diseasebreakdown → | 2025 | 40 |
| 3 | 2024 | 8 | |
| 4 | 2022 | 6 | |
| 5 | 2021 | 1 | |
| 6 | 2021 | 11 | |
| 7 | 2021 | 28 | |
| 8 | 2020 | 31 | |
| 9 | 2020 | 34 | |
| 10 | 2019 | 29 | |
| 11 | 2019 | 32 | |
| 12 | 2018 | 5 | |
| 13 | 2017 | 1 | |
| 14 | [DNA diagnostics in dementia]. | 2017 | 1 |
| 15 | 2017 | 19 | |
| 16 | 2016 | 4 | |
| 17 | Souvenaid (R) Improves Memory in Drug-Naive Patients with Mild Alzheimer's Disease: Results from a Randomized, Controlled, Double-Blind Study (Souvenir II) | 2012 | 3 |
| 18 | 2007 | 126 | |
| 19 | 2006 | 409 | |
| 20 | 1999 | 1 |
About Philip Scheltens
Philip Scheltens is a scholar working on Psychiatry and Mental health, Neurology, Physiology, Cognitive Neuroscience and Neurology, having authored 1.2k papers that have together received 100.6k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (674 papers), Alzheimer's disease research and treatments (463 papers), Functional Brain Connectivity Studies (200 papers), Neurological Disease Mechanisms and Treatments (155 papers), Advanced Neuroimaging Techniques and Applications (125 papers), Cerebrovascular and Carotid Artery Diseases (63 papers), EEG and Brain-Computer Interfaces (59 papers) and Health Systems, Economic Evaluations, Quality of Life (55 papers). The work is most often cited by research in Psychiatry and Mental health (43.9k citations), Neurology (18.2k citations), Cognitive Neuroscience (29.8k citations), Physiology (36.4k citations) and Neurology (13.0k citations). Philip Scheltens has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Frederik Barkhof, Wiesje M. van der Flier, Cornelis J. Stam, Serge A.R.B. Rombouts, Clifford R. Jack, Martin N. Rossor, Yolande A.L. Pijnenburg, María C. Carrillo, John C. Morris and David S. Knopman. Their work appears in journals such as Alzheimer s & Dementia, Neurology, Alzheimer s Research & Therapy, Journal of Alzheimer s Disease and Neurobiology of Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.